Researchers present findings of the first prospective clinical trial assessing ipilimumab 1mg/kg plus pembrolizumab for melanoma following progressed on anti-PD-1 (programmed cell death protein-1) immunotherapy.
Publications
Prognostic value of ctDNA mutation in melanoma: A meta-analysis
The selection of the studies was carried out using PubMed, EMBASE, Web of Science, and Cochrane databases to evaluate the prognostic value of the presence or change in circulating tumor DNA (ctDNA) mutations in patients with melanoma.
United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019
Researchers used the Global Burden of Disease 2019, to assess skin cancer burden in the US from 1990 to 2019.
Genomic risk score for melanoma in a prospective study of older individuals
Researchers evaluated an updated polygenic risk score (PRS) for its performance in a population of older people, where melanoma incidence as well as cumulative ultraviolet radiation exposure is greatest.